CS200214B2 - Method of preparing indazole derivatives - Google Patents
Method of preparing indazole derivatives Download PDFInfo
- Publication number
- CS200214B2 CS200214B2 CS792040A CS204079A CS200214B2 CS 200214 B2 CS200214 B2 CS 200214B2 CS 792040 A CS792040 A CS 792040A CS 204079 A CS204079 A CS 204079A CS 200214 B2 CS200214 B2 CS 200214B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- acetyl
- benzyl
- formula
- compounds
- benzyl ether
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 125000003453 indazolyl group Chemical class N1N=C(C2=C1C=CC=C2)* 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims description 12
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- -1 alkali metal salt Chemical class 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- QHDRKFYEGYYIIK-UHFFFAOYSA-N isovaleronitrile Chemical compound CC(C)CC#N QHDRKFYEGYYIIK-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- HHBUAAXHXWSZAG-UHFFFAOYSA-N 2,5-dimethyl-3-nitrophenol Chemical class CC1=CC(O)=C(C)C([N+]([O-])=O)=C1 HHBUAAXHXWSZAG-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- WDEGJQYOPQDMHW-UHFFFAOYSA-N n-(2-methyl-3-phenylmethoxyphenyl)acetamide Chemical compound CC(=O)NC1=CC=CC(OCC=2C=CC=CC=2)=C1C WDEGJQYOPQDMHW-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- RVDRWZKPARNFLI-UHFFFAOYSA-N 1,3-dimethyl-2-nitro-4-phenylmethoxybenzene Chemical compound CC1=C([N+]([O-])=O)C(C)=CC=C1OCC1=CC=CC=C1 RVDRWZKPARNFLI-UHFFFAOYSA-N 0.000 description 1
- NKMYQGLBYGGNHE-UHFFFAOYSA-N 1,3-dimethyl-4-nitro-2-phenylmethoxybenzene Chemical compound CC1=CC=C([N+]([O-])=O)C(C)=C1OCC1=CC=CC=C1 NKMYQGLBYGGNHE-UHFFFAOYSA-N 0.000 description 1
- SGJSDGAQLYNPLF-UHFFFAOYSA-N 1-(4-hydroxy-5-methylindazol-1-yl)ethanone Chemical compound C(C)(=O)N1N=CC2=C(C(=CC=C12)C)O SGJSDGAQLYNPLF-UHFFFAOYSA-N 0.000 description 1
- AZNDUHNNESEBSM-UHFFFAOYSA-N 1-(4-hydroxy-6-methylindazol-1-yl)ethanone Chemical compound C1=C(C)C=C2N(C(=O)C)N=CC2=C1O AZNDUHNNESEBSM-UHFFFAOYSA-N 0.000 description 1
- QNTUJXIVMMRPEW-UHFFFAOYSA-N 1-(4-hydroxy-7-methylindazol-1-yl)ethanone Chemical compound C1=CC(C)=C2N(C(=O)C)N=CC2=C1O QNTUJXIVMMRPEW-UHFFFAOYSA-N 0.000 description 1
- NRENIBFGGVDEDM-UHFFFAOYSA-N 1-(4-hydroxyindazol-1-yl)ethanone Chemical compound C1=CC=C2N(C(=O)C)N=CC2=C1O NRENIBFGGVDEDM-UHFFFAOYSA-N 0.000 description 1
- QSJAYNUXMYHEFZ-UHFFFAOYSA-N 1-(4-phenylmethoxyindazol-1-yl)ethanone Chemical compound C1=CC=C2N(C(=O)C)N=CC2=C1OCC1=CC=CC=C1 QSJAYNUXMYHEFZ-UHFFFAOYSA-N 0.000 description 1
- UTMPXLMLLKITKD-UHFFFAOYSA-N 1-(5-methyl-4-phenylmethoxyindazol-1-yl)ethanone Chemical compound CC1=CC=C2N(C(=O)C)N=CC2=C1OCC1=CC=CC=C1 UTMPXLMLLKITKD-UHFFFAOYSA-N 0.000 description 1
- TWXDGTXHMPFRLY-UHFFFAOYSA-N 1-(6-ethyl-4-hydroxyindazol-1-yl)ethanone Chemical compound CCC1=CC(O)=C2C=NN(C(C)=O)C2=C1 TWXDGTXHMPFRLY-UHFFFAOYSA-N 0.000 description 1
- CAZQKUOWMNFVLT-UHFFFAOYSA-N 1-(6-ethyl-4-phenylmethoxyindazol-1-yl)ethanone Chemical compound C=12C=NN(C(C)=O)C2=CC(CC)=CC=1OCC1=CC=CC=C1 CAZQKUOWMNFVLT-UHFFFAOYSA-N 0.000 description 1
- SVWXZUHRSUDOAY-UHFFFAOYSA-N 1-(6-methyl-4-phenylmethoxyindazol-1-yl)ethanone Chemical compound C1=C(C)C=C2N(C(=O)C)N=CC2=C1OCC1=CC=CC=C1 SVWXZUHRSUDOAY-UHFFFAOYSA-N 0.000 description 1
- RSEIOLMCPVFVNU-UHFFFAOYSA-N 1-(7-methyl-4-phenylmethoxyindazol-1-yl)ethanone Chemical compound C1=CC(C)=C2N(C(=O)C)N=CC2=C1OCC1=CC=CC=C1 RSEIOLMCPVFVNU-UHFFFAOYSA-N 0.000 description 1
- YILIWPRHODZCMA-UHFFFAOYSA-N 1-[4-(oxiran-2-ylmethoxy)indazol-1-yl]ethanone Chemical compound C1=CC=C2N(C(=O)C)N=CC2=C1OCC1CO1 YILIWPRHODZCMA-UHFFFAOYSA-N 0.000 description 1
- XZAOAFNAKJBVRA-UHFFFAOYSA-N 2,5-dimethyl-1-nitro-3-phenylmethoxybenzene Chemical compound [O-][N+](=O)C1=CC(C)=CC(OCC=2C=CC=CC=2)=C1C XZAOAFNAKJBVRA-UHFFFAOYSA-N 0.000 description 1
- KMXQUVMDZUGZIA-UHFFFAOYSA-N 2,6-dimethyl-3-phenylmethoxyaniline Chemical compound CC1=C(N)C(C)=CC=C1OCC1=CC=CC=C1 KMXQUVMDZUGZIA-UHFFFAOYSA-N 0.000 description 1
- PBSZHNXXFIYDBU-UHFFFAOYSA-N 2-methyl-1-nitro-3-phenylmethoxybenzene Chemical compound C1=CC=C([N+]([O-])=O)C(C)=C1OCC1=CC=CC=C1 PBSZHNXXFIYDBU-UHFFFAOYSA-N 0.000 description 1
- IHMXLABJHKKMTC-UHFFFAOYSA-N 2-methyl-3-phenylmethoxyaniline Chemical compound CC1=C(N)C=CC=C1OCC1=CC=CC=C1 IHMXLABJHKKMTC-UHFFFAOYSA-N 0.000 description 1
- JLRKNILWFUILKJ-UHFFFAOYSA-N 5-ethyl-2-methyl-1-nitro-3-phenylmethoxybenzene Chemical compound [O-][N+](=O)C1=CC(CC)=CC(OCC=2C=CC=CC=2)=C1C JLRKNILWFUILKJ-UHFFFAOYSA-N 0.000 description 1
- UJGNFASCJOYAHM-UHFFFAOYSA-N 5-methyl-4-phenylmethoxy-1h-indazole Chemical compound CC1=CC=C2NN=CC2=C1OCC1=CC=CC=C1 UJGNFASCJOYAHM-UHFFFAOYSA-N 0.000 description 1
- WTNCCUOYMPXXOJ-UHFFFAOYSA-N 6-methyl-4-phenylmethoxy-1h-indazole Chemical compound C=12C=NNC2=CC(C)=CC=1OCC1=CC=CC=C1 WTNCCUOYMPXXOJ-UHFFFAOYSA-N 0.000 description 1
- UTAZKQRKYUPPHU-UHFFFAOYSA-N 7-methyl-4-phenylmethoxy-1h-indazole Chemical compound C1=2C=NNC=2C(C)=CC=C1OCC1=CC=CC=C1 UTAZKQRKYUPPHU-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002473 indoazoles Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- HXQDDGJWCKGECC-UHFFFAOYSA-N n-(2,4-dimethyl-3-phenylmethoxyphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(C)C(OCC=2C=CC=CC=2)=C1C HXQDDGJWCKGECC-UHFFFAOYSA-N 0.000 description 1
- HQHCBVXHMXNQAN-UHFFFAOYSA-N n-(2,5-dimethyl-3-phenylmethoxyphenyl)acetamide Chemical compound CC(=O)NC1=CC(C)=CC(OCC=2C=CC=CC=2)=C1C HQHCBVXHMXNQAN-UHFFFAOYSA-N 0.000 description 1
- DCDDSUGWDNKHBU-UHFFFAOYSA-N n-(5-ethyl-2-methyl-3-phenylmethoxyphenyl)acetamide Chemical compound CCC1=CC(NC(C)=O)=C(C)C(OCC=2C=CC=CC=2)=C1 DCDDSUGWDNKHBU-UHFFFAOYSA-N 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Vynález se týká způsobu přípravy indazolových derivátů obecného vzorce I, (I) r' ve kterém znamenáThe invention relates to a process for the preparation of indazole derivatives of the general formula (I) in which:
R] vodík nebo alkylovou skupinu s 1 až 4 atomy uhlíku,R 1 is hydrogen or C 1 -C 4 alkyl,
R' vodík nebo acetylovou nebo benzoylovou skupinu,R 'is hydrogen or an acetyl or benzoyl group,
R2 benzyl nebo vodík, jestliže R' značí acetylovou nebo benzoylovou skupinu.R 2 is benzyl or hydrogen when R 'is acetyl or benzoyl.
Bylo zjištěno, že nové sloučeniny obecného vzorce I představují cenné meziprodukty pro přípravu prospěšných, farmakologicky účinných látek. Nejprve se mohou připravit ze sloučenin obecného vzorce I, kde Rg je benzyl, příslušné 4-hydroxysloučeniny, které se potom nechají reagovat, popřípadě přímo, s reaktivními N-alkylovými alkylaminy nebo přes vhodné mezistupně, například 3-indazolyl-(4)~oxy-propanol-(2)-aminy, které jsou vhodné jako inhibitory adrenoergických beta-receptorů k léčení nebo profylaxi srdečních a oběhových onemocnění; například reakcí 1-acetyl-4-(2,3-epoxypropoxy)indazolu s isopropylaminem se získá 1-[indazolyl-(4)-oxy3-3-isopropylaminopropanol-(2).The novel compounds of formula I have been found to be valuable intermediates for the preparation of beneficial, pharmacologically active substances. Initially, the corresponding 4-hydroxy compounds can be prepared from compounds of formula I wherein R 8 is benzyl, which are then reacted, optionally directly, with reactive N-alkyl alkylamines or via suitable intermediates, for example 3-indazolyl- (4) oxy -propanol- (2) -amines useful as inhibitors of adrenoergic beta-receptors for the treatment or prophylaxis of cardiac and circulatory diseases; for example, treatment of 1-acetyl-4- (2,3-epoxypropoxy) indazole with isopropylamine affords 1- [indazolyl- (4) -oxy-3-isopropylaminopropanol- (2).
Reakcemi s jinými složkami se mohou z nich připravit také antialergicky účinné látky a látky působící na oběh krevní.Antiallergic active substances and substances acting on the blood circulation can also be prepared by reaction with other components.
Způsob přípravy sloučenin obecného vzorce I se vyznačuje tlm, že se sloučenina obecného vzorce II,A process for the preparation of compounds of formula I is characterized in that the compound of formula II
ve kterémin which
Rj má výše uvedený význam,Rj is as defined above,
Rg znamená benzylovou skupinu, r znamená acetylovou nebo benzoylovou skupinu, nitrosuje, cyklizuje a potom se popřípadě odětěpí benzylová nebo acetylové nebo benzoylová skupina, přičemž se takto získané sloučeniny obecného vzorce I popřípadě mohou dodatečně přeměnit na jiné sloučeniny obecného vzorce I.Rg is benzyl, r is acetyl or benzoyl, nitrosated, cyclized and then optionally cleaved a benzyl or acetyl or benzoyl group, whereby the compounds of the formula I thus obtained may optionally be converted into other compounds of the formula I.
Podle tohoto způsobu se 3-acylamino-2-methylfenylbenzylether obecného vzorce II nitrosuje (například isoamylnitrilem)v aprotickém rozpouštědla (například toluenu) za přítomnosti anhydridu a soli alkalického kovu a kyseliny odpovídající acylovému zbytku a zahříváním se cyklizuje. Potom se může benzylová skupina získané sloučeniny snadno hydrogenolyticky odštěpit.According to this method, the 3-acylamino-2-methylphenylbenzyl ether of formula II is nitrosated (e.g. with isoamylnitrile) in an aprotic solvent (e.g. toluene) in the presence of an anhydride and an alkali metal salt and acid corresponding to the acyl residue and cyclized by heating. Thereafter, the benzyl group of the compound obtained can be readily hydrogenolytically cleaved.
Dostatečná přeměna sloučenin vzorce I na jiné sloučeniny vzorce I se může provádět podle známých metod.Sufficient conversion of compounds of formula I to other compounds of formula I may be carried out according to known methods.
Rovněž je možné ze sloučenin obecného vzorce I, kde R' znamená acylovou skupinu, tuto selektivně odstranit za mírných podmínek aminolýzou nebo hydrolýzou, tj. bez změny dalších funkčních skupin.It is also possible to selectively remove it under mild conditions by aminolysis or hydrolysis, i.e. without altering other functional groups, from the compounds of formula I wherein R 'is an acyl group.
Příprava sloučenin podle vynálezu bude blíže popsána v následujících příkladech.The preparation of the compounds of the invention will be described in more detail in the following examples.
Příklad 1Example 1
1-Acetyl-4-benzoyloxyindazol1-Acetyl-4-benzoyloxyindazole
Směs 64 g (3-acetamido-2-methyl-fenyl)benzyletheru, 25 g octanu sodného, 69 ml acetanhydridu, 50 ml lsoamylnitrilu a 2 1 toluenu se míchá 15 až 20 hodin při 80 až 90 °C.A mixture of 64 g of (3-acetamido-2-methylphenyl) benzyl ether, 25 g of sodium acetate, 69 ml of acetic anhydride, 50 ml of isoamylnitrile and 2 l of toluene is stirred at 80-90 for 15-20 hours.
Po ochlazení na 10 °C se sůl odsaje a filtrát se zahustí ve vakuu do sucha. Roztíráním zbytku s 300 ml methanolu se získá 47,5 g téměř bezbarvých krystalů, t. t. 97 °C.After cooling to 10 ° C, the salt is filtered off with suction and the filtrate is concentrated to dryness in vacuo. Trituration of the residue with 300 ml of methanol yielded 47.5 g of almost colorless crystals, m.p. 97 ° C.
(3-Acetamido-2-methyl-fenyl)benzyl’ether použitý jako výchozí látka se získá následujícím způsobem ve dvou reakčních stupních:The (3-acetamido-2-methylphenyl) benzyl ether used as the starting material is obtained in the following two steps:
(3-Amino-2-mathyl-fenyl)benzylether(3-Amino-2-methylphenyl) benzyl ether
Redukcí (2-methyl-3-nitrofenyl)benzyletheru hydražinhydrátem a Raneyovým niklem v methanolu se získá jako surový produkt zelený olej.Reduction of (2-methyl-3-nitrophenyl) benzyl ether with hydrazine hydrate and Raney nickel in methanol yields a green oil as a crude product.
(3-Acetamid -2-methyl-fenyl)benzylether(3-Acetamide -2-methylphenyl) benzyl ether
Acetylací výše popsaného produktu acetanhydridem v toluenu: bezbarvé krystaly, t. t.Acetylation of the product described above with acetic anhydride in toluene: colorless crystals, m.p.
142 až 143 °C (z toluenu).142-143 ° C (from toluene).
Příklad 2Example 2
1-Aeetyl-4-benzyloxy-6-methylindazol1-Methyl-4-benzyloxy-6-methylindazole
2002,42002.4
Směs 149 g (3-acetamido-2,5-dimethyl-fenyl)benzyletheru, 50 g octanu sodného, 138 ml anhydridu kyseliny octové, 50 ml isoamylnitrilu a 3 1 toluenu se míché 15 až 20 hodin při 80 až 90 °C. Po ochlazeni se odsaje, filtrát se zahusti ve vakuu do sucha, zbytek se rozpustí v oca 300 ml methanolu, načež produkt za studená krystaluje. Výtěžek: 103 g nažloutlých krystalů, b. t. 91 až 93 °C;A mixture of 149 g of (3-acetamido-2,5-dimethyl-phenyl) benzyl ether, 50 g of sodium acetate, 138 ml of acetic anhydride, 50 ml of isoamylnitrile and 3 l of toluene is stirred at 80-90 ° C for 15-20 hours. After cooling, it is filtered off with suction, the filtrate is concentrated to dryness in vacuo, the residue is dissolved in 300 ml of methanol and the product is crystallized in a cold state. Yield: 103 g of yellowish crystals, mp 91-93 ° C;
(3-Acetamido-2,5-dlmethyl-fenyl)benzylether použitý v příkladu 2 jako výchozí létka se připraví následujícími reakcemi z 2,5-dimethyl-3-nitrofenolů:The (3-Acetamido-2,5-dlmethyl-phenyl) benzyl ether used in Example 2 as a starting material was prepared by the following reactions from 2,5-dimethyl-3-nitrophenols:
(2,5-Dlmethyl-3-nitrofenyl)benzylether(2,5-Dimethyl-3-nitrophenyl) benzyl ether
Směs 433 g 2,'5-dimethyl-3-nitrofenolu, 360 g uhličitanu draselného, 326 ml benzylchloridu a 2 litrů dimethylformamidu se míchá přes noc při 50 °C. Odsaje se, filtrát se zahustí ve vakuu do sucha, zbytek se nalije na 4.1 ledové vody a po odsátí a vysuěenl na vzduchu se získá 668 g nažloutlých,krystalů, b. t. 66 až 68 °C.A mixture of 433 g of 2,5-dimethyl-3-nitrophenol, 360 g of potassium carbonate, 326 ml of benzyl chloride and 2 liters of dimethylformamide was stirred overnight at 50 ° C. It is suctioned off, the filtrate is concentrated to dryness in vacuo, the residue is poured into 4.1 g of ice-water and after suctioning and air-drying 668 g of yellowish crystals are obtained, m.p. 66-68 ° C.
(3-Amino-2,5-dimethylfenyl)benzyle ther(3-Amino-2,5-dimethylphenyl) benzyl ther
Výěe popsané nitrosloučenina se redukuje hydrazinhydrétem za použití Raneyova niklu v methanolu. Jako surový produkt se získá v dobrém výtěžku hnědý olej.The nitro compound described above was reduced with hydrazine hydrate using Raney nickel in methanol. A brown oil is obtained in good yield as a crude product.
(3-Aoetamido-2,5-dimethylfenyl)benzylether(3-Aoetamido-2,5-dimethylphenyl) benzyl ether
Acetylací výše popsaného produktu acetanhydridem v toluenu: bezbarvé krystaly, b. t.Acetylation of the product described above with acetic anhydride in toluene: colorless crystals, m.p.
169 až 171 °C (z toluenu).M.p. 169-171 ° C (from toluene).
Analogickým postupem se získá:An analogous procedure yields:
a) z (3-acetamido-2,6-dimethylfenyl)-benzyletheru (t. t. 161 až 162 °C) [připraveného přes (2,6-dimethyl-3-nitrofenyl)benzylether a (3-amino-2,6-dimethylfenyl)benzyletherja) from (3-acetamido-2,6-dimethylphenyl) -benzyl ether (mp 161-162 ° C) [prepared via (2,6-dimethyl-3-nitrophenyl) benzyl ether and (3-amino-2,6-dimethylphenyl) ) benzyletherj
1-aoetyl-4-benzyloxy-5-methylindazol, t. t. 108 až 109 °C;1-acetyl-4-benzyloxy-5-methylindazole, mp 108-109 ° C;
b) z (3-aoetamido-2,4-dimethylfenyl)benzyletheru (t. t. 160 až 162 °C) [připraveného přes (2,4-dimethyl-3-nitrofenyl)benzylether, t. t. 65 až 67 °C, a (3-amino-2,4-dimethylfenyl )benzyletherjb) from (3-azetamido-2,4-dimethylphenyl) benzyl ether (mp 160-162 ° C) [prepared via (2,4-dimethyl-3-nitrophenyl) benzyl ether, mp 65-67 ° C, and (3- amino-2,4-dimethylphenyl) benzyl ether
1-acetyl-4-benzyloxy-7-methylindazol, b. t. 90 až 92 °C;1-acetyl-4-benzyloxy-7-methylindazole, mp 90-92 ° C;
c) z (2-methyl-3-acetamido-5-ethylfenyl)benzyletheru (b. t. 139 až 140 °C), [připraveného přes (2-methyl-3-nitro-5-ethylfenyl)benzylether a (2-methyl-3-amino-5-ethylfenyl)benzyletherjc) from (2-methyl-3-acetamido-5-ethylphenyl) benzyl ether (mp 139-140 ° C), [prepared via (2-methyl-3-nitro-5-ethylphenyl) benzyl ether and (2-methyl-3) (amino-5-ethylphenyl) benzyl ether
1-aoetyl-4-benzyloxy-6-ethylindazol, t. t, 109,5 až 1,0,5 °C.1-Acetyl-4-benzyloxy-6-ethylindazole, mp, 109.5-1.5 ° C.
Příklad 3Example 3
4-Benzyloxy-6-methylindazol4-Benzyloxy-6-methylindazole
0,5 g ,-acetyl-4-benzyolxy-6-methylindazolu se nechá stát 1 hodinu v 10 ml isopropylaminu při teplotě místnosti, zahustí se ve vakuu do sucha a zbytek se překrystaluje ze směsi methanol-voda za použití aktivního uhlí. Výtěžek: 0,2 g bezbarvých krystalů, b. t. 105 až 107 °C.0.5 g of n-acetyl-4-benzyolxy-6-methylindazole was allowed to stand for 1 hour in 10 ml of isopropylamine at room temperature, concentrated to dryness in vacuo and the residue was recrystallized from methanol-water using charcoal. Yield: 0.2 g of colorless crystals, mp 105-107 ° C.
Analogickým způsobem se získá:In an analogous manner there are obtained:
a) 4-benzyloxy-5-methylindazol, t. t. 94 až 95 °Cja) 4-benzyloxy-5-methylindazole, m.p. 94-95 ° C;
b) 4-benzyloxy-7-methylindazol, b. t. 175 až 177 °C.b) 4-benzyloxy-7-methylindazole, m.p. 175-177 ° C.
Příklad 4Example 4
1-Acetyl-4-hydroxyindazol1-Acetyl-4-hydroxyindazole
Hydrogenolýzou 1-acetyl-4-benzyloxyindazolu za přítomnosti palédia na uhlí (10%) v methanolu při atmosférickém tlaku se získají béžové krystaly, t. t. 140 až 142 °C (z vody)Hydrogenolysis of 1-acetyl-4-benzyloxyindazole in the presence of palladium on carbon (10%) in methanol at atmospheric pressure gives beige crystals, m.p. 140-142 ° C (from water)
Příklad 5Example 5
1-Acetyl-4-hydroxy-6-methylindazol1-Acetyl-4-hydroxy-6-methylindazole
Analogicky podle příkladu 4 se zífcká hydrogenací 1-acetyl-4-benzyloxy-6-metbylindazolu produkt krystalující z methanolu v bledénažloutlých krystalech, b. t. 191 až 192 ^C.Analogously to Example 4, the product crystallizing from methanol in pale yellowish crystals, m.p. 191-192 ° C, was obtained by hydrogenation of 1-acetyl-4-benzyloxy-6-methylindazole.
Analogicky se získé:By analogy, it is obtained:
a) 1-acetyl-4-hydroxy-5~methylindazol, b. t. 185 až 186 °C;(a) 1-acetyl-4-hydroxy-5-methylindazole, m.p. 185-186 ° C;
b) 1-acetyl-4-hydroxy-7-methylindazol, b. t. 135 až 136 °C;b) 1-acetyl-4-hydroxy-7-methylindazole, m.p. 135-136 ° C;
cT 1-acetyl-4-hydroxy-6-ethylindazol, b. t. 161 až 163 °C.mp 161-163 ° C, 1-acetyl-4-hydroxy-6-ethylindazole.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS792040A CS200214B2 (en) | 1976-04-30 | 1979-03-28 | Method of preparing indazole derivatives |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2619165A DE2619165C2 (en) | 1976-04-30 | 1976-04-30 | Indazole derivatives and processes for their preparation |
CS772840A CS200213B2 (en) | 1976-04-30 | 1977-04-29 | Method of preparing indazole derivatives |
CS792040A CS200214B2 (en) | 1976-04-30 | 1979-03-28 | Method of preparing indazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CS200214B2 true CS200214B2 (en) | 1980-08-29 |
Family
ID=25745697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS792040A CS200214B2 (en) | 1976-04-30 | 1979-03-28 | Method of preparing indazole derivatives |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS200214B2 (en) |
-
1979
- 1979-03-28 CS CS792040A patent/CS200214B2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4880810A (en) | Quinazolinediones and pyridopyrimidinediones | |
US5464872A (en) | Arylalkyl (thio) amides | |
EP0146228B1 (en) | Substituted 2-mercapto-imidazoles and their preparation and use | |
NO309648B1 (en) | Indole derivative and pharmaceutical preparation containing this | |
DD148774A5 (en) | PROCESS FOR THE PREPARATION OF AMINOOPROPANOL DERIVATIVES | |
EP0165422B1 (en) | Substituted bis-(4-aminophenyl)-sulphones, their preparation and their use as medicines | |
US4824953A (en) | Multi-step process for producing 5-hydroxy-N-(6-oxo-piperidyl-methyl)-2-(2,2,2-trifluoro-ethoxy)-benzamide and derivatives | |
CA1189859A (en) | 1-phenyl-2-aminocarbonylindole compounds, preparation thereof and pharmaceutical compositions containing them | |
DE2905876A1 (en) | NEW PIPERIDINOPROPYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
DE2737630C2 (en) | ||
EP0034116A2 (en) | N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines | |
SU1041033A3 (en) | Process for preparing derivatives of aminopropanol or their salts | |
US4668688A (en) | N-substituted isoquinoline derivatives and pharmaceutical compositions containing them | |
US4797403A (en) | Quinazolinediones and pyridopyrimidinediones | |
CS200214B2 (en) | Method of preparing indazole derivatives | |
JPS63145286A (en) | Bicyclic imidazole derivative | |
US2540946A (en) | Pyridoxal-histamine and processes for preparing the same | |
PL115906B1 (en) | Process for preparing novel derivatives of indazole | |
DK169406B1 (en) | Hydroxyalkoxy-4-phenylpropylindole compounds, their preparation and drugs containing them | |
US4835175A (en) | Indole derivatives pharmaceutical preparations based thereon, and β-receptor stimulation therewith | |
FR2710066A1 (en) | Derivatives of 1- [2-amino-5- [1- (triphenylmethyl-1H-imidazol-4-yl] -1-oxopentyl] piperidine, their preparation and their use as synthesis intermediates. | |
JPS6045577A (en) | 2-azabicylo(2,2,2)octane derivative | |
JP2726653B2 (en) | Diaminopyrimidine derivative | |
US4803284A (en) | Processes for the preparation of 3-amino-2-(5-methoxy-1H-indol-3-yl) propionic acid monohydrate | |
GB2023590A (en) | 3-amino-2-(5-fluoro and 5- methoxy-1H-indol-3-yl) Propanoic Acid Derivatives and Their Preparation and Use |